share_log

12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga ·  Apr 9 04:31

Gainers

  • Kineta (NASDAQ:KA) shares increased by 24.3% to $0.67 during Monday's after-market session. The market value of their outstanding shares is at $7.3 million.
  • Moleculin Biotech (NASDAQ:MBRX) stock increased by 10.21% to $5.6. The company's market cap stands at $12.4 million.
  • Cue Health (NASDAQ:HLTH) stock moved upwards by 6.01% to $0.18. The market value of their outstanding shares is at $29.3 million.
  • Nexalin Technology (NASDAQ:NXL) shares moved upwards by 5.57% to $2.46. The company's market cap stands at $18.2 million.
  • Atara Biotherapeutics (NASDAQ:ATRA) stock moved upwards by 5.52% to $0.8. The market value of their outstanding shares is at $95.2 million.
  • PetVivo Hldgs (NASDAQ:PETV) stock rose 5.26% to $1.02. The market value of their outstanding shares is at $17.1 million.

Losers

  • BioSig Technologies (NASDAQ:BSGM) stock fell 16.9% to $1.03 during Monday's after-market session. The company's market cap stands at $9.6 million.
  • Scinai Immunotherapeutics (NASDAQ:SCNI) shares decreased by 11.92% to $0.43. The market value of their outstanding shares is at $1.8 million.
  • Processa Pharma (NASDAQ:PCSA) shares fell 5.87% to $2.81. The market value of their outstanding shares is at $4.7 million.
  • GRI Bio (NASDAQ:GRI) shares fell 4.31% to $0.52. The market value of their outstanding shares is at $1.6 million.
  • Pluri (NASDAQ:PLUR) stock fell 3.75% to $5.39. The market value of their outstanding shares is at $28.1 million.
  • Biofrontera (NASDAQ:BFRI) stock decreased by 3.54% to $1.91. The company's market cap stands at $9.7 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment